{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023189","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.658234+00:00","generated_at":"2026-05-17T15:05:24.438093+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncotelic Therapeutics enters consulting agreements with Jefferson Capital and Valor Nation for strategic services","bullets":["Engaged Jefferson Capital Ventures and Valor Nation for 18-month consulting and advisory services starting August 6, 2025.","Jefferson receives $20,000/month cash and up to 20,320,930 restricted stock awards tied to milestones: market cap >$100M, $10M equity increase, uplisting.","Valor receives 4,064,586 shares of common stock immediately upon signing.","Jefferson's RSAs vest in thirds per milestone; unvested shares forfeited if milestones not achieved.","Shares issued under Section 4(a)(2) exemption from Securities Act registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023189","json":"https://secwatch.observer/filing/0001641172-25-023189.json","markdown":"https://secwatch.observer/filing/0001641172-25-023189.md","text":"https://secwatch.observer/filing/0001641172-25-023189.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000164117225023189/0001641172-25-023189-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000164117225023189/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T15:05:24.438093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}